There was no evidence of heterogeneity between NT-pro BNP and saxagliptin (p for interaction = 0.46), although the absolute risk excess for heart failure with saxagliptin was greatest in the highest NT-pro-BNP quartile (2.1%) [80]. This evidence concerns the gene NPPB and heart failure.